NEW YORK (GenomeWeb News) – Pathway Genomics and Susan G. Komen today said they are partnering to educate women about screening options available for detecting a genetic predisposition for breast cancer.
By Matt Jones
NEW YORK (GenomeWeb News) – Michigan State University has won a $450,000 grant from the Susan G. Komen for the Cure foundation to conduct studies focused on gene expression in breast cancer tumors.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Susan G. Komen for the Cure foundation has granted $3.5 million to a trio of research institutes to study triple-negative breast cancer in African and African-American women.
The team plans to use sequencing to create a polyepitope DNA vaccine that will contain "fragments from each individual mutated protein" for individual patients. They hope to begin human trials for the vaccine within the next two years.
"Identification and validation of mutations in individual breast cancers provides an unprecedented opportunity to target unique tumor antigens with personalized breast cancer vaccines," the researchers wrote in their project abstract.
Despite pleas of breast cancer advocates to maintain access to Avastin using gene markers to identify those most likely to benefit, there is little evidence to suggest that the drug company or regulatory experts are considering this strategy.